Stock Analiz

Keros Therapeutics, Inc. (KROS) stock forecast and price target

Price $10.30 · data as of November 13, 2026

12-month price target

Average target$19.83
Upside / downside+92.6%
Analysts6
ConsensusBuy
Low $16.00Average $19.83High $25.00

Gold marker: average target · white marker: today’s price ($10.30)

Analyst ratings

Strong buy 0Buy 4Hold 3Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-3.35−245.7%$41M
Next fiscal year
ends December 31, 2027
$-5.96−78.0%$14M
Next quarter
ends December 31, 2026
$-1.41−63.9%$428570
Quarter after
ends March 31, 2027
$-1.51−24.8%$0

Consensus of the analysts covering Keros Therapeutics, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Keros Therapeutics stock price target?

The average 12-month target from 6 analysts is $19.83, 92.6% above the current price of $10.30 Targets range from $16.00 to $25.00.

Is Keros Therapeutics a buy according to analysts?

The consensus rating is “Buy” (4 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Keros Therapeutics expected to earn?

Analysts expect EPS of $-3.35 for the fiscal year ending December 31, 2026 and $-5.96 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.